Intima media thickness of common carotid arteries is associated with traditional risk factors and presence of ischaemic heart disease in hemodialysis patients.
暂无分享,去创建一个
[1] F. Locatelli,et al. Hypertension and cardiovascular risk assessment in dialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] L. Iacoviello,et al. Homocysteinemia in patients with type 1 diabetes in relation to renal function. , 2001, Diabetes Care.
[3] J. Małyszko,et al. Correlation between carotid intima–media thickness and hematocrit and hemoglobin values in renal transplant recipients , 2001, Clinical transplantation.
[4] G. London,et al. Cardiovascular risk in end-stage renal disease: vascular aspects. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[5] D. Wilcken,et al. Homocysteine and cardiovascular disease: cause or effect? , 2000, The American journal of clinical nutrition.
[6] Colin Baigent,et al. Premature cardiovascular disease in chronic renal failure , 2000, The Lancet.
[7] Mohamed,et al. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. , 2000, Kidney international.
[8] J. Spence,et al. Validation of an enzyme immunoassay for the determination of total homocysteine in plasma. , 2000, Blood Coagulation and Fibrinolysis.
[9] C. Zoccali. Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] H. Makino,et al. The Significance of Atherogenic Indices in Patients on Hemodialysis , 2000, American Journal of Nephrology.
[11] H. Philippou,et al. Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. , 2000, Circulation.
[12] K. Harjai. Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen , 1999, Annals of Internal Medicine.
[13] S. Nishi,et al. Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients. , 1999, Kidney international. Supplement.
[14] M. Schreiber,et al. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. , 1999, Kidney international.
[15] A. Levey,et al. Epidemiology of Cardiac Disease in Dialysis Patients , 1999 .
[16] C. Berne,et al. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. , 1999, Kidney international.
[17] A. Hofman,et al. Cross‐sectionally assessed carotid intima–media thickness relates to long‐term risk of stroke, coronary heart disease and death as estimated by available risk functions , 1999, Journal of internal medicine.
[18] S. Sirrs,et al. Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] R. Krauss,et al. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1999, Circulation.
[20] R. Kronmal,et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.
[21] G. Boers,et al. Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[22] E. Ritz,et al. Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] I. Rosenberg,et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[24] A. Folsom,et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.
[25] T. Shoji,et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. , 1995, Kidney international.
[26] P. Ridker,et al. Plasma concentration of lipoprotein(a) and the risk of future stroke. , 1995, JAMA.
[27] D. Grobbee,et al. Carotid artery intima‐media thickness as an indicator of generalized atherosclerosis , 1994, Journal of internal medicine.
[28] P. Ridker,et al. A prospective study of lipoprotein(a) and the risk of myocardial infarction. , 1993, JAMA.
[29] W. Koenig,et al. The possible role of hemorheology in atherothrombogenesis. , 1992, Atherosclerosis.
[30] E G Lowrie,et al. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[31] S. Rostand,et al. Dialysis-associated ischemic heart disease: insights from coronary angiography. , 1984, Kidney international.
[32] Eary,et al. CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .
[33] A. Donker,et al. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[34] F. Kronenberg,et al. Lipoprotein(a) in renal disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] W Riley,et al. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. , 1996, Stroke.
[36] S. Thompson,et al. Haemostatic function and cardiovascular death: early results of a prospective study. , 1980, Lancet.